Primary Neuroendocrine Tumor in a Horseshoe Kidney With Positive 111In-Pentetreotide Somatostatin Receptor Scintigraphy and Negative 18F-DOPA PET/CT. (November 2015)

• Record Type: Journal Article
• Authors: Gauthé, Mathieu; Lièvre, Astrid; Alberini, Jean-Louis
• Is Part Of: Clinical nuclear medicine. Volume 40:Number 11(2015)
• Publication Date: 2015-11
• Subjects: Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000000911
• Languages: English
• ISSNs: 0363-9762

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Abstract</title> <p>Primary renal neuroendocrine tumors (NETs) are low-grade tumors with neuroendocrine differentiation and have been reported to arise most commonly in renal abnormalities such as horseshoe kidney. We report a case of a 54-year-old woman with history of invasive ductal breast carcinoma presenting several liver lesions. Histological findings finally revealed liver locations of a well-differentiated NET. Imaging workup combining somatostatin receptor scintigraphy and ¹⁸F-DOPA PET/CT finally enable proper diagnosis of primary renal NET located on the isthmus of a horseshoe kidney.</p> </sec> </abstract>